The emerging field of stem cell nutrition has the potential to eclipse the massive antioxidant supplement business according to the boss of the Californian firm responsible for creating a completely new category in nutritional supplements.<\/p>\n
Ray Carter Jr, CEO of Stemtech International, was speaking to NutraIngredients-USA after signing a multi-million dollar deal with Australian biotech firm Marinova to include its proprietary Fucoidan ingredients in Stemtechs new SE2 supplement. <\/p>\n
The next generation of Stemtechs best-selling StemEnhance supplement, SE2 also includes a concentrate of blue-green algae Aphanizomenon flos-aquae (AFA), the herb Polygonum multiflorum and the fungus Cordyceps sinensis. <\/p>\n
Adult stem cells, tissue maintenance and repair <\/p>\n
SE2 helps increase the number of adult stem cells or master cells that are released into the bloodstream before migrating into tissues where they reproduce and become new healthy cells, effectively helping the body renew and repair itself, claimed Carter. <\/p>\n
Stemtech products have already generated more than $200m in sales since 2005, he added: Stem cell nutrition addresses a brand new way to support health [and]has the potential to eclipse the massive antioxidant supplement business. <\/p>\n
When consumers first heard the words stem cell, they were inundated with media reports about the controversy and promise of embryonic stem cell (ESC) research. <\/p>\n
Fast forward to today, and they are beginning to learn that adult stem cells actually show much more clinical promise without the ethical and moral controversy surrounding ESCs. <\/p>\n
The bodys natural renewal system <\/p>\n
Adult stem cellshave been shown to be the bodys natural renewal system, he claimed. <\/p>\n<\/p>\n
View original post here: The emerging field of stem cell nutrition has the potential to eclipse the massive antioxidant supplement business according to the boss of the Californian firm responsible for creating a completely new category in nutritional supplements. Ray Carter Jr, CEO of Stemtech International, was speaking to NutraIngredients-USA after signing a multi-million dollar deal with Australian biotech firm Marinova to include its proprietary Fucoidan ingredients in Stemtechs new SE2 supplement. Continue reading
\nStemtech: Stem cell nutrition could eclipse antioxidant supplement market<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"